Managed Healthcare Executive September 1, 2025
Researchers suggest that access to treatment and socioeconomic resources can influence glycemic control and disparities in the management of patients with Type 1 diabetes.
More people with Type 1 diabetes are using continuous glucose monitoring and insulin delivery devices to better manage their disease, but there are still disparities across race, ethnicity, and socioeconomic status for the use of these technologies and for glucose control, finds a new study recently published in JAMA Network Open.
“While we should be celebrating the improvements, we must remember that most patients with Type 1 diabetes don’t have optimal glucose control, and there is a lot of room for improvement,” study senior author Jung-Im Shin, M.D., Ph.D., associate professor in the Johns Hopkins Bloomberg...
Today's Sponsors
Today's Sponsor